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Background and methods
The cAMP responsive element modulator CREMa is a
transcriptional repressor and putatively important in T
cell pathophysiology of Systemic Lupus Erythematosus
(SLE). To clarify the relevance of CREMa we overexpressed
CREMa under control of the T cell specific CD2 promoter
in mice.
Results
As expected, overall T cell proliferation in naive T cells as
response to different stimuli like anti-CD3 or an allogenic
MLR was diminished in CREMa transgenic mice com-
pared to wildtype mice, however-unexpectedly – disease
activity in a contact dermatitis model was more severe in
transgenic mice. Moreover, when T cells purified from the
lymphnodes of the challenged ears were used for prolifer-
ation assays, transgenic T cell showed an enhanced prolif-
erative response. Additionally, T cells from transgenic
mice displayed an enhanced IL-17 production.
Conclusion
These data suggest that murine T cells with a transgenic
overexpression of CREMa show an anergic phenotype in
vitro, however when challenged in an in vivo disease
model they react in a way, which predisposes to autoim-
munity. Thus these T cells partially mimic the phenotype
of human SLE T cells and support the relevance of CREMa
for the pathophysiology of SLE.
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